Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
Molecular genetic profiling reveals novel association between FLT3 mutation and survival in glioma.
Mutational profiles of gliomas significantly differed based on WHO Grade.
»
05/01/20
Promoter methylation of tumor suppressor genes induced by human papillomavirus in cervical cancer.
HPV E7 could induce CADM1 promoter methylation and decrease gene expression.
»
08/01/19
Is Schistosomiasis a Risk Factor for Bladder Cancer? Evidence-Based Facts.
Some data support association between schistosomiasis and bladder cancer in sub-Saharan Africa.
»
03/06/20
Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data.
ER-negative tumour incidence decreased among all ages.
»
01/02/20
MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma
TGFβ receptor 1 inhibitor SB431542 reduced SOX4 expression and increased cisplatin sensitivity.
»
06/26/20
Opening large-conductance potassium channels selectively induced cell death of triple-negative breast cancer
Treatment with BK channel opener significantly slowed tumor growth without cardiac toxicity.
»
06/26/20
Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration
Integration of IF miRNAs and mRNAs unveiled networks associated with patient clinicopathological traits.
»
06/30/20
Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study
Simultaneous dose reduction to hippocampus and HT-P area did not compromise PTV coverage.
»
06/30/20
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma
Studies validate analytical performance of clonoSEQ Assay.
»
06/30/20
Integration of genomics, metagenomics, and metabolomics to identify interplay between susceptibility alleles and microbiota in adenoma initiation
Metabolomics pathway analysis facilitated identification of functionally relevant private noncoding variant.
»
06/29/20
< Prev
Next >